 |
J&J to buy Swiss medical firm for $20bnJohnson & Johnson is in preliminary talks to acquire Swiss medical device maker Synthes for a price which could be about $20 billion, a source familiar with the situation said on Saturday. A deal at that price would mark an 11 per cent More… |
 |
J&J to cut 6-7pc of workforceJohnson & Johnson will eliminate about 6 percent to 7 percent of its global workforce, or some 7,000 to 8,000 positions, as the diversified healthcare company restructures and seeks cost savings, the company said on Tuesday. The compan More… |
 |
J&J, nonprofit in TB drug tie-upHealthcare company Johnson & Johnson said on Wednesday it has joined with the nonprofit Global Alliance for TB Drug Development to speed commercialisation of its experimental tuberculosis drug, known as TMC207. The drug, designed to in More… |
 |
China clears Johnson & Johnson productsChinese health authorities said on Saturday that they had found no evidence of cancer-causing chemicals in baby products made by US company Johnson & Johnson. The State Food and Drug Administration had investigated 33 products, includi More… |
|
Johnson & Johnson products safe says ChinaChinese health authorities said on Saturday that they had found no evidence of cancer-causing chemicals in baby products made by US company Johnson & Johnson. The State Food and Drug Administration had investigated 33 products, includi More… |
 |
J&J to acquire Israel's Omrix for $465mJohnson & Johnson Inc will acquire Israel's Omrix Biopharmaceuticals Inc for $27 a share, or a total of $465 million, the Globes financial news website said on Monday. Omrix, which makes biosurgical sealants for the prevention of b More… |
